Age-dependent impairment in endothelial function and arterial stiffness in former high class male athletes is no different to that in men with no history of physical training by Majerczak, Joanna et al.
Age-Dependent Impairment in Endothelial Function and Arterial
Stiffness in Former High Class Male Athletes Is No Different to That in
Men With No History of Physical Training
Joanna Majerczak, MD, PhD; Marcin Grandys, PhD; Marzena Frołow, MD, PhD; Zbigniew Szkutnik, PhD, DSc; Agnieszka Zakrzewska, PhD;
Rafał Ni_zankowski, MD, PhD; Krzysztof Duda, MD, PhD; Stefan Chlopicki, MD, PhD; Jerzy A. Zoladz, PhD, DSc
Background-—Physical activity is generally considered to exert positive effects on the cardiovascular system in humans. However,
surprisingly little is known about the delayed effect of professional physical training performed at a young age on endothelial function
and arterial stiffness in aging athletes. The present study aimed to assess the impact of long-lasting professional physical training
(endurance and sprint) performed at a young age on the endothelial function and arterial stiffness reported in older age in relation to
glycocalyx injury, prostacyclin and nitric oxide production, inflammation, basal blood lipid profile, and glucose homeostasis.
Methods and Results-—This study involved 94 male subjects with varied training backgrounds, including young athletes (mean age
 25 years), older former high class athletes (mean age  60 years), and aged-matched untrained control groups. Aging
increased arterial stiffness, as reflected by an enhancement in pulse wave velocity, augmentation index, and stiffness index
(P<104), as well as decreased endothelial function, as judged by the attenuation of flow-mediated vasodilation (FMD) in the
brachial artery (P=0.03). Surprisingly, no effect of the training performed at a young age on endothelial function and arterial
stiffness was observed in the former athletes. Moreover, no effect of training performed at a young age (P>0.05) on blood lipid
profile, markers of inflammation, and glycocalyx shedding were observed in the former athletes.
Conclusions-—Our study clearly shows that aging, but not physical training history, represents the main contributing factor
responsible for decline in endothelial function and increase in arterial stiffness in former athletes. ( J Am Heart Assoc. 2019;8:
e012670. DOI: 10.1161/JAHA.119.012670.)
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A ge is an independent risk factor of cardiovasculardisease (CVD), given that more than 90% of all CVD
(hypertension, coronary and peripheral artery disease, and
stroke) occurs at ages above 40.1,2 An increased risk of CVD
with aging is mechanistically linked to an impairment of
endothelial function and an increased stiffness of large elastic
conduit arteries. In fact, endothelial dysfunction and
increased arterial stiffness have a prognostic significance in
age-dependent increase in CVD.2,3 Age-dependent endothelial
dysfunction is mainly linked to a decrease in nitric oxide (NO•)
bioavailability and related to an enhancement of oxidative
stress accompanied by chronic low-grade inflammation
occurring with aging.3 The lowering of NO• bioavailability with
age leads to proinflammatory, proliferative, hypercoagulative,
and vasoconstrictive states in vessels that may contribute to
an increased risk of CVD.4,5 Interestingly, a decrease in NO•
bioavailability has been found to be implicated in an
enhancement of vascular fibrosis and arterial stiffness.6,7
On the other hand, it has been well documented that
regular aerobic physical activity reduces cardiovascular risk in
middle-aged and older adults.2 This effect might be partly
explained by a training-induced reduction of cardiovascular
risk factors, such as hyperlipidemia, hypertension, and insulin
resistance, as well as by an improvement of NO•-dependent
endothelial function and an attenuation of arterial stiffen-
ing.8,9 Accordingly, a very strong evidence concerning the
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positive impact of physical activity on CVD risk factors has
been pointed out by Fiuza-Luces et al,9 underlying that in the
Hadza people of Tanzania, who spend 950 minutes each week
on moderate-to-vigorous physical activity (ie, 6-fold greater
than 150 minutes per week—the minimum of physical
activity recommended by the World Health Organization), no
cardiovascular risk factors are present.9 Those results confirm
the suggestion that the impact of physical activity on
cardiovascular health is “dose” dependent.10
Surprisingly little is known about the effect of professional
long-lasting physical training performed at a young age on
endothelial function and arterial stiffness in former athletes in
older age. In the present study, we hypothesized that age-
dependent endothelial dysfunction and increased arterial
stiffness, as the strong predictors of CVD, are delayed in
former athletes (endurance trained and sprinters) when
compared with age-matched controls. We tested this hypoth-
esis and assessed the impact of aging and physical training
history on endothelial function and arterial stiffness in a group
of men in relation to nitric oxide and prostacyclin production,
markers of endothelial glycocalyx integrity, signs of systemic
inflammation, blood lipid profile, and glucose homeostasis.
Endothelial function in the present study was evaluated by
brachial flow-mediated dilation (FMD). Arterial stiffness of
central elastic arteries was determined by central augmenta-
tion index (AI), whereas peripheral arterial stiffness was
determined by carotid-radial pulse wave velocity (PWV)
measurements and stiffness index (SI) calculation.11 More-
over, additional CVD risk factors, such as central systolic
blood pressure (cSBP), central pulse pressure (cPP), and
carotid intima-media thickness (cIMT; as an index of subclin-
ical atherosclerosis), were determined.
Methods
The data that support the findings of this study are available
from the corresponding author upon reasonable request.
Subjects
Ninety-four male subjects participated in this study: 47 young
men (Y group, <45 years old; min–max, 18–43) and 47 older
men (O group, >45 years old; min–max, 48–75). The group of
young men (Y) consisted of 15 endurance-trained young
athletes (Y-End, n=15), 15 sprint-trained young athletes (Y-Sp,
n=15), and 17 untrained young controls (Y-Con, n=17). The
group of older men (O) consisted of 16 former endurance-
trained athletes (O-End, n=16), 15 former sprint-trained
athletes (O-Sp, n=15), and 16 untrained older controls (O-
Con, n=16). Physical training background and basic anthro-
pometric data for all studied groups are given in Table 1.
All 4 groups of athletes (Y-End, Y-Sp, O-End, and O-Sp)
consisted of individuals who currently (Y-End and Y-Sp) or
previously (O-End and O-Sp) conducted several years of
professional physical training (sprint or endurance) and
successfully competed in their sporting events at a national
and international level, including country championships,
world championships, and the Olympics. The young athletes
(Y-End and Y-Sp) at the time of study performed high-intensity
training (790 versus 800 minutes per week, respectively,
for Y-End and Y-Sp). The former athletes (O-End and O-Sp) at
young age performed high-intensity professional training
(1130 versus 730 minutes per week, respectively, for O-
End and O-Sp), which was then followed by several years
(from 15 to 44 years versus from 16 to 44 years, respec-
tively, for O-End and O-SP) of low-to-average amount of
physical activity per week ( 120 minutes per week;
Table 1). Two untrained groups of subjects (both young and
older) served as age-matched controls (Y-Con and O-Con).
The subjects that were recruited to this study had no
history of serious metabolic, cardiovascular or endocrine
disease (or any other known medical condition); however,
some of the older subjects presented stage 1 hypertension
and were taking blood pressure therapy (monotherapy, ie, 8
men from O-Con, 1 from O-End, and 1 from the O-Sp group).
Moreover, additionally to blood pressure therapy, 2 subjects
from O-Con group used statins. None of the subjects smoked
or had any other addiction (eg, alcohol or drugs).
Study Design
The study started with a medical health examination, basic
anthropometric measurements, physical activity, and training
background questionnaire. Based on this information, the 6
groups of subjects were identified and a comprehensive blood
Clinical Perspective
What Is New?
• Former athletes at an older age display a comparable age-
dependent decline in endothelial function and age-depen-
dent increase in arterial stiffness to individuals with no
history of physical training at a young age.
• This study shows that an age-related decline in endothelial
function and an increase in arterial stiffness in former aged
athletes are not dependent upon history of training
performed at a young age.
What Are the Clinical Implications?
• Professional sprint or endurance training performed at a
young age is not harmful to endothelial function and arterial
stiffness in young athletes.
• The potential beneficial effects of physical training per-
formed at a young age disappear at the course of aging.
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analysis was performed in each subject, including morpho-
logical, biochemical, and endothelial marker measurements.
Moreover, a noninvasive assessment of endothelial function
and arterial stiffness was conducted (see below).
Ethical Approval
The study was conducted with the permission of the Local
Ethical Committee (No. 48/KBL/OIL/2009), according to the
principles established in the Declaration of Helsinki for
research on human subjects. All volunteers provided written
consent for participation in the study after becoming
acquainted with the procedures and purpose of the study.
Anthropometric Measurements
Anthropometric measurements were performed in the morn-
ing, around 15 minutes before blood sampling. Body mass
and height of each subject were measured using standard
procedures and equipment (Radwag WPT 150; Radwag Wagi
Elektroniczne, Radom, Poland), and body fat percentage was
determined with a bioelectrical impedance analyzer (UM-018;
TANITA Europe GmbH, Sindelfingen, Germany).
Noninvasive Assessment of Endothelial Function
and Arterial Wall Stiffness
On the vascular testing day, subjects were instructed to
report to the laboratory between 7:30 and 10:00 AM after
12 hours fasting and abstain from caffeine, vitamin supple-
ments, and exercise. Tests were performed in the supine
position in a quiet, semidarkened, and temperature-controlled
(22–25°C) room after a 20-minute rest period to obtain a
hemodynamically steady state. Heart rate was monitored
continuously using a 3-lead ECG. A 14950 cm automatic cuff
(Vendys; Endothelix, Inc., Palo Alto, CA) was placed around
the right forearm.
Flow-mediated dilation
Endothelial function was assessed using FMD of the brachial
artery. According to theguidelines, thebrachial arterywas imaged
above the antecubital fossa in the longitudinal plane, whereas the
occlusion cuff was placed on the forearm.12 The brachial artery
was imaged using a 14-MHz linear-array transducer (Acuson
S2000; Siemens, Erlangen, Germany). At baseline, time-averaged
velocity was measured and 10-second videos were recorded in
order tomeasure thearterial diameter. A pressurecuffwasplaced
distal to the imaged area and inflated 40 mm Hg above the
patients’ systolic pressure for 5 minutes. Immediately after
releasing the cuff, maximal blood velocity was measured, and
15 seconds after the release, a 120-second video of brachial
artery dilation in B-mode was recorded.
Results were obtained by means of a wall-tracking
computer system developed in the JCET laboratory.13 Maximal
diameter was obtained with a semiautomatic technique,
operating on the basis of the 2 regions of interest, marked by
the operator on the first frame of the ultrasound video. The
algorithm for tracking the borders of the arterial walls was
based on the active contour method.14 It worked indepen-
dently for each wall, starting with the initial borders, and
marked by the operator.
Central blood pressure, PWV, pulsewave analysis, andAI
cSBP and central diastolic blood pressure were measured
noninvasively using the SphygmoCor system (AtCor Medical
Pty Ltd, West Ryde, Australia). cPP was calculated as a
difference between central systolic and diastolic pressure.
Moreover, using this system, PWV was determined at the
carotid and radial arterial sites.15 Pulse wave analysis was
performed with the calculation of arterial stiffness parameters
Table 1. Basic Characteristics of the Studied Group of Men
Y-Con (n=17) Y-End (n=15) Y-Sp (n=15) O-Con (n=16) O-End (n=16) O-Sp (n=15)
Age, y 22.02.3 26.88.1 23.22.7 60.66.7 60.48.2 59.16.2
Height, cm 1785.8 1806.0 1846.4 1745.9 1755.1 1817.5
Body mass, kg 72.65.2 70.94.9 77.46.7† 79.710.0* 78.19.3* 87.811.1*,†
BMI, kg/m2 23.11.5 21.80.9 22.81.2 26.32.5* 25.73.5* 26.83.3*
Body fat, % 15.62.5 13.11.8 13.21.5 26.13.9* 24.26.5* 24.86.5*
Current physical activity, h/wk 2.31.0 13.24.0 13.43.6 1.21.7 2.161.8 (18.87.1)‡ 2.531.8 (12.21.9)‡
Training experience, y . . . 11.47.2 8.43.0 . . . 14.93.4§ 14.13.5§
Data are given as meanSD. The symbol “*” marks the significant differences between young and older men within the subgroups ie, control, endurance and sprint (*P<0.001, Tukey’s
post hoc test), whereas the symbol “†” marks the significant effects of performed training (sprint or endurance) in respect to age-matched control group (†P<0.001,Tukey’s post hoc test).
BMI indicates body mass index; Y-Con, young control group; Y- End, young endurance trained athletes; Y-Sp, young sprinters; O-Con, older control group; O-End, older endurance trained
athletes; O-Sp, older sprinters. Additionally, in the case of older distance runners (O-End) and sprinters (O-Sp), data concerning physical activity level in hours per week (‡) and the training
experience in years (§) during the period of their professional training are given.
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(AI). The SphygmoCor Pulse Wave Velocity Assessment (PWV)
system uses applanation tonometry in conjunction with a 3-
lead ECG to take sequential measurements at 2 arterial sites.
Timing of the onset of systole of the pressure waves was
compared with the timing of the corresponding R waves on
the ECG recording, with the time delay calculated by the
software. The distance from the suprasternal notch to the
carotid artery site and the distance from the suprasternal
notch to the radial artery site were measured in meters by
using a standard measuring tape. The pressure-sensitive
transducer (tonometer) was applied to the carotid and radial
artery sites along with 3 ECG leads attached to the subjects’
chest in order to measure the transit time of the pulse wave
from the left ventricle to the carotid artery (t1) and from the
left ventricle to the radial artery (t2), respectively. Carotid-
radial PWV in individual measurements was calculated as the
distance difference between the radial and carotid divided by
the difference between t1 and t2 and was used as a measure
of peripheral arterial stiffness.
Pulse wave analysis was performed based on the pulse
detection at the radial artery with an applanation tonometry
sensor using the SphygmoCor system pulse. Aortic pulse from
radial pulse was estimated noninvasively using a mathemat-
ical model.16,17 When aortic pulse was obtained, the shape of
the aortic pressure pulse was analyzed and calculations were
performed to obtain AI, defined as a percentage of the cPP
attributed to the reflected pulse wave.18
Stiffness index
The SI, a noninvasive indirect technique of measuring arterial
stiffness peripherally, was measured by infrared photoplethys-
mography using the PulseTrace apparatus (CareFusion, Bas-
ingstoke, UK). The measurement was based on digital volume
pulse measurements, given that the timing of the reflected
wave (diastolic component) relative to the direct wave
(systolic component) of the pulse wave depends on large
artery stiffness. The peak-to-peak time of systolic and
diastolic components of the pulse wave is an estimation of
the propagation time of the reflected wave. Assuming that the
arterial tree length is proportional to the subject body height,
the SI was defined as the subject body height divided by the
peak (systolic) to peak (diastolic) time. SI=Subject body
height/dt where dt is peak to peak time.
Carotid intima-media thickness
cIMT was measured by ultrasound scan (Acuson S2000;
Siemens, Erlangen, Germany). cIMT measurements were
obtained with the patient lying in the supine position. First,
a transverse scan of the common carotid artery was
performed from the base of the neck to the carotid bulb to
identify a possible focal intima-media thickness thickening
and atherosclerotic plaques. Next, each side common carotid
artery image from longitudinal postero- and anterolateral
scans were obtained to measure intima-media thickness.
cIMT was measured in the near and far walls in the most
thickened area of each vessel. At least 2 cIMT scans were
obtained for each near and far wall. Optimal B-mode settings
of gain, depth, focal zone placement, and compression were
individually adjusted for each vessel to enhance arterial wall
structures and image quality. cIMT was measured by the
syngo Arterial Health Package software program, which
provides a method for quantifying cIMT. The Arterial Health
Package program uses semiautomated border detection to
determine the maximum and average thickness of the intima-
medial layer of the carotid artery.
Blood Sampling
Blood samples from the antecubital vein were taken at rest in
the fasting state between 7:30 and 9:00 AM. Blood for
parameters analyzed in plasma (pl), that is, tumor necrosis
factor-a ([TNF-a]pl), interleukin-6 ([IL-6]pl), nitrite ([NO

2 ]pl),
nitrate ([NO3 ]pl), and prostacyclin metabolite [6-keto-PGF1a]pl,
was collected in plain tubes containing EDTA and then
centrifuged at 653g for 15 minutes at 4°C.
Blood for parameters analyzed in serum (s), that is, glucose
([Glu]s), lipid profile, prealbumin ([Prealbumin]s), C-reactive
protein ([CRP]s), a-acid glycoprotein ([AAG]s), insulin ([INS]s),
and hyaluronic acid ([HA]s) concentrations, was collected in
plain tubes with a clotting activator and left to clot for a
minimum of 30 minutes at room temperature. Then, samples
were centrifuged at 1469g for 10 minutes at 4°C. Plasma and
serum were stored at 80°C until analysis.
Blood Parameter Analysis
Serum glucose ([Glu]s), total serum cholesterol ([TC]s),
triacylglycerol ([TG]s), high-density lipoprotein cholesterol
([HDL]s), and low-density lipoprotein cholesterol ([LDL]s)
concentrations were measured on a Cobas c501 analyzer
(Roche Diagnostics, Mannheim, Germany), using an enzyme
hexokinase method ([Glu]s) and an enzymatic colorimetric
method ([TC]s, [TG]s, [HDL]s, [LDL]s). [CRP]s, [AAG]s and
[Prealbumin]s, were determined by immunonephelometry on a
BN-ProSpec analyzer (Siemens, Marburg, Germany) and
ferritin by the chemiluminescence method using the Architect
i1000SR analyzer (Abbott Laboratories, Chicago, IL).
Insulin concentration was measured by electrochemilumi-
nescence immunoassay using a Cobas e411 analyzer (Roche
DiagnosticsGmbH,Mannheim, Germany). Detection limitswere
0.8 nmol/L. The intra- and interassay coefficients of variation
for this measurement were <2.1% and 2.9%, respectively.
Interleukin 6 ([IL-6]pl) concentration was determined by
ELISA, according to the directions provided by the kit
DOI: 10.1161/JAHA.119.012670 Journal of the American Heart Association 4
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manufacturers (R&D Systems, Inc., Minneapolis, MN). The
detection limit was 0.039 ng/L. The intra- and interassay
coefficients of variation for this measurement were <8% and
10%, respectively.
Estimation of plasma nitrite ([NO2 ]pl), nitrate ([NO

3 ]pl),
[TNF-a]pl, [6-keto-PGF1a]pl, and serum hyaluronic acid ([HA]s)
concentrations were evaluated as previously described.19,20
Moreover, the homeostatic model assessment of insulin
resistance (HOMA-IR) was calculated as follows: HOMA-IR =
[Insulin (lU/mL)9Glucose (mmol/L)]/22.5.
Statistical Analysis
The results obtained in this study are presented as means,
SDs, and 95% CIs. The data points that deviated from the
group means by more than 3 SDs were treated as outliers and
excluded from further analysis.
In order to quantify the dependence of noninvasive
parameters of arterial stiffness and endothelial function
(FMD) on body composition in the studied group of subjects
(n=94), Spearman’s rank-correlation coefficient was used
because of the non-normal pooled data distributions.
In order to analyze the impact of “age” and “training in
youth” on the presented variables, the data were analyzed
using 2-way ANOVA with a post hoc Tukey test performed to
identify significant differences between groups. Normality of
distribution was tested with the Shapiro-Wilk test. Homo-
geneity of variance was tested using the Levene test. No
serious violations of the assumptions were detected (the
fraction of rejected null hypotheses in this multiple testing
was roughly of the order of the assumed significance level).
The size of the data set was limited by the number of
former professional athletes available for the study. In order
to estimate the sensitivity of the experiment, some ANOVA
power calculations were performed. For the balanced 293
ANOVA design with total number of 90 observations, and for
the standard effect sizes f=0.1, 0.25, 0.40, conventionally
attributed to small, medium, and large effects, the powers of
the corresponding F-tests were 0.15, 0.65, and 0.96 for the
2-levels age effect, and 0.12, 0.53, and 0.92 for the 3-levels
training effect and for the interaction.
In the case of a few variables (PWV, [AAG]s, [IL-6]pl, and
[NO2 ]pl), when significant interactions between age and
training were found in 2-way ANOVA, a second-stage analysis
was performed with two 1-way ANOVA models with age-
matched control groups, fitted separately in the group of
young athletes (which were active at the time of measure-
ments) and in the group of older former athletes (who finished
their sport career  27 years before this study and did not
continued their training). The significant effects in ANOVA are
presented as least squares means and standard errors. The
significance of the differences with respect to control groups
was checked using Dunnett’s post hoc test with 2-sided P
values. Dunnett’s test is usually more powerful than Tukey’s
test, because of a smaller number of comparisons performed.
Hence, whenever the main interest is in comparisons to a
single natural reference group, Dunnett’s test is usually
preferred. This is the case in our separate studies of young (Y)
and older (O) groups in cases with significant interactions
detected in 2-way ANOVA. On the other hand, with 2-way
ANOVA, there is no single reference group and Dunnett’s test
could only be used separately for the 2 factors. It is then more
natural, however, to use Tukey’s test, and we did so.
Significance was set at P<0.05. The analysis was performed
with the statistical package, STATISTICA (version 13.1;
StatSoft, Tulsa, OK).
Results
Characteristics of the Studied Group of Men
Anthropometric data, basic blood parameters, and physical
training background characteristics for the studied men are
given in Table 1. The body composition of older men
(60.06.9 years) was characterized by a significantly
(P<0.05) higher body mass, body mass index (BMI), and body
fat, when comparedwith youngmen (23.95.3 years; Table 1).
The body mass of sprinters (young and older) was signifi-
cantly higher than in age-matched controls (Table 1) and higher
(P=0.006, Tukey’s post hoc test) than in endurance-trainedmen
(young and older). No effect of performed training on BMI and
body fat was reported (Table 1).
The Impact of Aging and Professional Physical
Training on the Arterial Wall Stiffness Indices and
Central Pressure in the Studied Group of Men
Older men were characterized by significantly higher central
AI (4.71.17 versus 27.21.17%, respectively, for Y and O
group; P<104; Figure 1A) and SI (6.60.33 versus
11.40.32 m/sec, respectively, for Y and O group; P<104;
Figure 1C) when compared with young men. An increase in
PWV with aging was influenced by performed training, as
observed from the significant interaction in the model for PWV
(P=0.03; Figure 1B). Endurance training at a young age
increases PWV (7.250.18 versus 7.780.19 m/sec,
respectively, for the Y-Con and Y-End group). However, after
training cessation, this effect seems to disappear and only the
general age-related increase was observed (7.480.13 versus
8.880.13 m/sec, respectively, for the Y and O group).
Moreover, higher cSBP (1081.4 versus 1301.4 mm Hg,
respectively, for Y and O men; P<104; Figure 1D), higher
diastolic blood pressure (711.1 versus 821.1 mm Hg,
respectively, for Y and O men; P<104), and higher cPP
DOI: 10.1161/JAHA.119.012670 Journal of the American Heart Association 5
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(37.41.0 versus 47.31.0 mm Hg, respectively, for Y and O
men; P<104; Figure 1E) has been found in older men when
compared with young men. In addition, a significantly greater
(P<104) cIMT was present in older men (0.730.02 mm)
compared with young men (0.450.02 mm; Figure 1F). No
effect of the type of training performed (endurance or sprint;
P>0.05) on central AI, SI, cSBP, central diastolic blood
pressure, and cPP and on cIMT was found in the group of
studied men (Figure 1A, 1C through 1F).
The Impact of Aging and Professional Physical
Training on the Endothelial Function and
Endothelial Glycocalyx Layer Integrity in the
Studied Group of Men
Endothelial function assessed by FMD was significantly atten-
uated in older men when compared with young men
(5.460.37 versus 4.110.36%, respectively, for Y and O
men; P=0.01; Figure 2A). In addition, a significant decrease in
plasma 6-keto-PGF1a (7202370 versus 4959357 pg/mL,
respectively, for Y and O men; P<104; Figure 2D) and plasma
nitrate concentration (30.431.50 versus 19.331.53 lmol/
L, respectively, for Y and Omen; P<104; Figure 2C) with aging
was found. A significant age-dependent increase in serum
hyaluronic acid concentration [HA]s—an indirect marker of
glycocalyx layer integrity—was observed (32.64.21 versus
65.64.21 ng/mL, respectively, for Y and O men; P<104;
Figure 1E). No effect of training on FMD, 6-keto-PGF1a, nitrate,
and hyaluronic acid concentration was present (P>0.05;
Figure 2A, 2C through 2E). Plasma nitrite concentration
increased with age in the control group (0.290.03 versus
0.450.04 lmol/L, respectively, for Y and O men; P=0.01),
whereas in former sprinters and endurance trained athletes, it
remained unchanged (Figure 2B).
The Impact of Aging and Professional Physical
Training on the Blood Lipid Profile and Glucose
Homeostasis
Age-dependent changes in blood lipid profile in the studied
group were characterized by significant increase in total
cholesterol (4.340.14 versus 5.440.14 mmol/L, respec-
tively, for Y and O men; P<104; Figure 3A), triacylglycerol
concentration (1.010.07 versus 1.290.07 mmol/L,
respectively, for Y and O men; P=0.008; Figure 3B),
LDL-cholesterol concentrations (2.550.13 versus
Figure 1. The impact of aging and the professional physical training (endurance or sprint) performed at young age on the arterial stiffness
parameters, central arterial pressures, and carotid-intima media thickness in the studied group (n=94). Central augmentation index (central AI;
A); pulse wave velocity (PWV; B); stiffness index (SI; C), central systolic blood pressure (cSBP; D); central pulse pressure (cPP; E); and carotid
intima-media thickness (cIMT; F). Y-Con, young control group; Y-End, young endurance trained athletes; Y-Sp, young sprinters; O-Con, older
control group; O-End, older endurance trained athletes; O-Sp, older sprinters. Boxes and whiskers represent, correspondingly, the 95% CIs for
means and SDs. The effect of aging is shown by different colors of boxes and whiskers (blue for young and red for older groups of subjects), and
the effect of training is marked by different box templates (striped pattern for endurance trained athletes and checkered pattern for sprinters).
The impact of factors: Age and Training on the analyzed variables is presented (2-way ANOVA, 2-sided P value). In case of PWV, significant
interaction between the factors was detected (2-way ANOVA, Age*Training).
DOI: 10.1161/JAHA.119.012670 Journal of the American Heart Association 6
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3.620.13 mmol/L, respectively, for Y and O men; P<104;
Figure 3D) whereas no changes in HDL-cholesterol concen-
tration with aging were observed (1.480.05 versus
1.420.05 mmol/L, respectively, for Y and O men; Fig-
ure 3C). No impact of performed training on the lipid profile
was observed, except a clear tendency (P=0.07) to higher
HDL-cholesterol concentration in endurance-trained athletes
when compared with age-matched controls (1.600.06
versus 1.410.06 mmol/L, respectively, for the End and
Con group; Figure 3C). Moreover, endurance-trained ath-
letes revealed a significantly higher HDL-cholesterol con-
centration (1.600.06 versus 1.350.06 mmol/L,
respectively, for endurance-trained athletes and sprinters;
P=0.01; Figure 3C) than sprinters of the same age.
Aging was accompanied by a significant increase in basal
blood glucose concentration (4.950.08 versus
5.490.08 mmol/L, respectively, for Y and O men; P<104;
Figure 3E) and an enhancement of HOMA-IR (1.220.12 versus
1.690.12, respectively, for Y and O men; P=0.005; Figure 3F).
No effect of training (P>0.05) on blood glucose concentrationwas
observed (Figure 3E). A clear tendency (P=0.06, Tukey’s post
hoc) to lower HOMA-IR has been observed in the groups of
endurance-trained young and older athletes when compared with
age-matched controls (1.170.15 versus 1.660.14, respec-
tively, for the End and Con group; Figure 3F).
The Impact of Aging and Professional Physical
Training on Blood Inflammatory Markers
Aging significantly increased blood inflammatory markers
such as serum C-reactive protein (0.3590.143 versus
1.3450.139 g/L, respectively, for Y and O men; P<104;
Figure 4A), serum prealbumin (0.2690.008 versus
0.2980.008 g/L, respectively, for Y and O men, P=0.01;
Figure 4B), plasma TNF-a (1.160.06 versus 1.510.06 pg/
mL, respectively, for Y and O men; P=0.0001; Figure 4D), and
serum ferritin concentration (649.0 versus 1449.1 ng/
mL, respectively, for Y and O men; P<104; Figure 4F). No
impact (P>0.05) of performed training on the above-
mentioned inflammatory markers was observed.
In the case of a-1-acid glycoprotein (AAG) and interleukin-6
concentrations, training performed at a young age modified
the age-dependent changes in these inflammatory markers.
Endurance training at a young age decreases AAG
Figure 2. The impact of aging and the professional physical training (endurance or sprint) performed at young age on the endothelial function
and glycocalyx layer integrity in the studied group of men (n=94). Flow-mediated dilation (FMD; A); plasma nitrite concentration ([NO2 ]pl,; B),
plasma nitrate concentration ([NO3 ]pl; C); plasma 6-keto-PGF1a ([6-keto-PGF1a]pl; D), and serum hyaluronic acid concentration ([HA]s; E). Y-Con,
young control group; Y-End, young endurance trained athletes; Y-Sp, young sprinters; O-Con, older control group; O-End, older endurance trained
athletes; O-Sp, older sprinters. Boxes and whiskers represent, correspondingly, the 95% CIs for means and SDs. The effect of aging is shown by
different colors of boxes and whiskers (blue for young and red for older groups of subjects), and the effect of training is marked by different box
templates (striped pattern for endurance trained athletes and checkered pattern for sprinters). The impact of factors: Age and Training on the
analyzed variables is presented (2-way ANOVA, 2-sided P value). In the case of [NO2 ]pl, a significant difference between Y-Con and O-Con is
shown (Tukey’s post hoc test).
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(0.6810.031 versus 0.5620.033 g/L, respectively, for the
Y-Con and Y-End group), but this effect seems to disappear
after training cessation and only the increase with age is
observed (0.640.02 versus 1.730.02 g/L, respectively,
for Y and O men; P=0.02; Figure 4C). Moreover, [AAG]s in
endurance-trained young athletes is significantly lower than in
the age-matched control group (P=0.02, Dunnett’s test),
whereas no effect of training performed in the past
(endurance or sprint) on [AAG]s is present in former athletes
when compared with age-matched controls (Figure 4C).
Professional training performed at a young age (endurance
and sprint) attenuates [IL-6]pl concentration, but this effect of
Figure 3. The impact of aging and the professional physical training (endurance or sprint) performed at
young age on the blood lipid profile and glucose homeostasis in the studied group of men (n=94). Serum
total cholesterol concentration ([TC]s; A); serum triacylglycerol concentration ([TG]s; B); serum high-density
lipoprotein cholesterol concentration ([HDL]s; C); serum low-density lipoprotein cholesterol concentration
([LDL]s; D); serum glucose concentration ([Glu]s; E); and the homeostatic model assessment of insulin
resistance (HOMA-IR; F). Y-Con, young control group; Y-End, young endurance trained athletes; Y-Sp, young
sprinters; O-Con, older control group; O-End, older endurance trained athletes; O-Sp, older sprinters. Boxes
and whiskers represent, correspondingly, the 95% CIs for means and SDs. The effect of aging is shown by
different colors of boxes and whiskers (blue for young and red for older groups of subjects), and the effect
of training is marked by different box templates (striped pattern for endurance trained athletes and
checkered pattern for sprinters). The impact of factors: Age and Training on the analyzed variables is
presented (2-way ANOVA, 2-sided P value). In the case of [HDL]s and HOMA-IR, the P value denoted a
difference between endurance-trained athletes and age-matched controls as well as between endurance-
trained athletes and sprinters of the same age (Tukey’s post hoc test).
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training disappeared with aging, as manifested by the
significant interaction (P=0.049; Figure 4E). A clear tendency
to lower [IL-6]pl in young sprinters when compared with the
age-matched control group was observed (1.320.16 versus
1.460.19 pg/mL, respectively, for Y and O men; P=0.06;
Dunnett’s test), whereas no effect of training performed at a
young age (sprint or endurance) was found in former athletes
on [IL-6]pl (Figure 4E).
Correlation Analysis
Based on the data showing that excess of fat or dysfunctional
fat tissue is involved in age-related metabolic dysfunction and
accelerates the onset of age-related diseases, including
cardiovascular disease,21 we have performed the correlation
analysis between body composition and cardiovascular risk
factors.
In the studied group of men (n=94), body fat indices, that
is, body fat percentage and BMI, correlated positively
(P<104) with the parameters of central and peripheral
arterial stiffness (central AI, PWV, and SI), central pressure
(cSBP, cPP), as well as with a marker of atherosclerosis—
cIMT. Moreover, body fat and BMI correlated positively with
blood glucose and insulin resistance as well as with total
cholesterol and LDL-cholesterol (Table 2).
In addition, we found that BMI and body fat percentage
correlated positively with inflammatory markers, including a
major proinflammatory cytokine—TNF-a as well as with a
marker of inflammation and oxidative stress—ferritin
(Table 2).
Discussion
The main finding of the present study is that professional
physical training (endurance or sprint) performed at a young
age by athletes competing at a national/international level did
not modify the age-dependent decline of endothelial function
and arterial stiffness with aging.
The Impact of Aging on Arterial Stiffness and
Endothelial Function
Age-dependent arterial stiffening and endothelial dysfunction
are recognized as strong, independent predictors of CVD,
Figure 4. The impact of aging and the professional physical training (endurance or sprint) performed at young age on the inflammatory
markers in the studied group of men (n=94). Serum C-reactive protein concentration ([CRP]s; A); serum prealbumin concentration
([Prealbumin]s; B); serum a-1-acid glycoprotein concentration ([AAG]s; C); plasma tumor necrosis factor a concentration ([TNF-a]pl; D); plasma
interleukin-6 concentration ([IL-6]pl; E); serum ferritin concentration ([Ferritin]s; F). Y-Con, young control group; Y-End, young endurance-trained
athletes; Y-Sp, young sprinters; O-Con, older control group; O-End, older endurance-trained athletes; O-Sp, older sprinters. Boxes and whiskers
represent, correspondingly, the 95% CIs for means and SDs. The effect of aging is shown by different colors of boxes and whiskers (blue for
young and red for older groups of subjects), and the effect of training is marked by different box templates (striped pattern for endurance trained
athletes and checkered pattern for sprinters). The impact of factors: Age and Training on the analyzed variables is presented (2-way ANOVA, 2-
sided P value). In the case of [AAG]s and [IL-6]pl, a significant interaction between the factors was detected (2-way ANOVA, Age*Training).
Moreover, in the case of [AAG]s, a significant difference between young endurance-trained athletes and age-matched controls is presented,
whereas in the case of [IL-6]pl, a significant difference is shown between young sprinters and age-matched controls (Dunnett’s test).
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affecting each other and accelerating in this way vascular
dysfunction.22
The background of an arterial stiffness is rather complex and
can occur as a result of changes in the vascular matrix (an
increase in collagen and its cross-linking accompanied by a
decrease in elastin) or the function of vascular smooth muscle
cells.23 As demonstrated, NO• bioavailability plays an important
role in this process, given that in the physiological condition,
NO• inhibits the cross-linking enzyme, transglutaminase 2 (TG2)
activity24 and a decrease in NO• leads to an increase in TG2
secretion to the extracellular matrix and its activation.6,7 TG2,
ubiquitously expressed in the vasculature, regulates vascular
stiffness not only through catalazing cross-linking of
extracellular matrix proteins, but also by changing the behavior
of smooth muscle cells (ie, their adhesion, motility, and
proliferation)25; hence, TG2 activity seems to be an important
link between endothelial dysfunction and arterial stiffening.
In the present study, we found, as others did before, that
aging is accompanied by a significant increase in arterial
stiffness (Figure 1A through 1C), central pressure (Figure 1D
through 1E), and cIMT (Figure 1F).26,27 The age-dependent
decrease in brachial FMD (Figure 2A), which reflects the
attenuation of NO•-mediated vascular smooth muscle relax-
ation,28,29 in addition to a decrease in plasma 6-keto-PGF1a—a
metabolite of prostacyclin (Figure 2D)—shows that age-
dependent endothelial dysfunction accompanies arterial stiff-
ness. When considering the decrease in basal releases of
plasma 6-keto-PGF1a, a metabolite of prostacyclin with aging
(Figure 2D), one should remember that this can increase the
risk of cardiac events during exercise30,31 and might contribute
to the decrease in the magnitude of VO2max—the key index of
humans’ exercise capacity, which also declines with aging.32,33
Moreover, we found that aging accelerates endothelial
glycocalyx shedding, as reflected by a higher serum hyaluronan
concentration in older men (Figure 2E), one of the indirect
indices of glycocalyx layer integrity. Endothelial glycocalyx, a
carbohydrate-rich gel layer localized between blood flow and
the endothelial cell surface, is one of the important regulator of
endothelial function and is a hallmark of vascular health.34 An
intact glycocalyx is critical to mechanotransduction, vascular
permeability, angiogenesis, and protection of endothelial cells
from plasma oxidants and inflammatory cytokines.34 Glycoca-
lyx degradation (by among others oxidative stress and inflam-
mation) inhibits NO• production in response to shear stress and
hence leads to a decrease in NO• bioavailability and endothelial
dysfunction.35,36 Interestingly, as recently shown, glycocalyx
deterioration occurring during primary aging is accompanied by
an impairment of microvascular perfusion and precedes age-
dependent vascular pathology.37 Therefore, age-dependent
glycocalyx degradation leading to micro- and macrovascular
dysfunction is suggested to be an important risk factor in
CVD.38 Our study clearly demonstrates that endothelial glyco-
calyx shedding with aging (Figure 2E) accompanies endothelial
dysfunction (Figure 2A) and arterial stiffening (Figure 1A
through 1C), which is in agreement with the data presented
by Machin et al.37
An attenuated endothelial function (Figure 2A), disturbed
glycocalyx integrity (Figure 2E), and an enhanced arterial
stiffness (Figure 1A through 1C) in older men compared with
younger men were accompanied by an age-dependent
increase in blood inflammatory markers, including plasma
TNFa, IL-6 (Figure 4D and 4E), and serum ferritin concentra-
tion (Figure 4F)—also recognized as an oxidative stress
marker.39 These results support the findings that glycocalyx
deterioration, endothelial dysfunction, and an increase in
Table 2. Spearman Correlations of Body Fat Indices With
Arterial Wall Stiffness and Endothelial Function Parameters As
Well As With Metabolic Profile and Blood Inflammatory
Markers in the Group of Men Aged 18 to 75 Years (n=94).
BMI, kg/m2 Body Fat, %
Central AI, % 0.54‡ 0.74‡
PWV, m/sec 0.49‡ 0.59‡
SI, m/sec 0.48‡ 0.70‡
Central SBP, mm Hg 0.60‡ 0.75‡
Central PP, mm Hg 0.45‡ 0.54‡
cIMT, mm 0.53‡ 0.67‡
FMD, % 0.05 0.14
[NO2 ]pl, lmol/L 0.16 0.09






[TC]s, mmol/L 0.44* 0.57
‡













The symbols represent the significance of the given correlation (*P<0.05; †P<0.01;
‡P<0.001). [NO2 ]pl indicates plasma nitrite concentration; [6-keto-PGF1a]pl, plasma
6-keto-PGF1a; [AAG]s, serum a-1-acid glycoprotein concentration; [CRP]s, serum
C-reactive protein; [Ferritin]s, serum ferritin concentration; [Glu]s, serum glucose
concentration; [HA]s, serum hyaluronan concentration; [HDL]s, serum high-density
lipoprotein cholesterol concentration; [IL-6]pl, plasma interleukin-6 concentration;
[LDL]s, serum low-density lipoprotein cholesterol concentration; [TC]s, serum total
cholesterol concentration; [TNF-a]pl, plasma tumor necrosis factor-a concentration;
BMI, body mass index; central AI, central augmentation index; central PP, central pulse
pressure; central SBP, central systolic blood pressure; cIMT, carotid-intima media
thickness; FMD, brachial flow-mediated dilation; HOMA-IR, homeostatic model
assessment of insulin resistance; PWV, pulse wave velocity; SI, stiffness index.
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arterial stiffening with aging is mainly dedicated to 2 mutually
driving processes, that is, an age-dependent increase in
oxidative stress and chronic low-grade inflammation.40,41
The background of an age-dependent increase in oxidative
stress and inflammation leading to vascular dysfunction is
suggested to be dedicated, among others, to the changes in
body composition with aging, specifically to an increase in body
fat,21,42,43 which has been shown to be a major contributor to
chronic low-grade inflammation.21 The proinflammatory cyto-
kine, TNF-a, produced by adipose tissue,44 is recognized as a
key factor involved in the arterial stiffening background, given
that it is involved in an increase of TG2 expression45–47 as well
as being implicated in the induction of proinflammatory,
procoagulant, and proliferative genes in vasculature.48 In
addition, TNF-a has been shown to increase arginase activity,
which, as a consequence, leads to a decrease in NO•
bioavailability.49
In the present study, an age-dependent increase in body fat
percentage, evenwithin the normal range (from14% in youngmen
to around 25% of body mass in older men; Table 1), might be
implicated in an increase in inflammation and oxidative stress
(Figure 4A through 4F) with aging, given that adipose tissue
becomes dysfunctional with aging.44 Indeed, as presented, body
fat percentage in the whole group of subjects (n=94) correlated
positively with inflammatory and oxidative stress markers
(Table 2). This result indicates that adipose tissue might be
involved in enhanced inflammation and oxidative stress with
aging. Finally, the strong, positive correlation between body fat
indices (BMI, body fat percentage) and arterial stiffness param-
eters (Table 2) clearly demonstrates that arterial stiffening, a
hallmark of vascular aging,3 depends on body fat content. This
probably results from age-dependent chronic low-grade inflam-
mation (reflected by an increased TNF-a) in which dysfunctional
adipose tissue plays an important role.21 This is in agreementwith
data presented recently by others.50,51
The Impact of Professional Physical Training
(Endurance Versus Sprint) on Arterial Stiffness and
Endothelial Function in Young and Older Athletes
It is generally accepted that endurance training of low-to-
moderate intensity exerts beneficial effects in the cardiovas-
cular system.9,52 Even short-term endurance training has
been shown to decrease oxidative stress53 and inflamma-
tion,54 enhance NO• bioavailability,55 and improve endothelial
glycocalyx layer integrity.56 It needs to be underlined that
regular aerobic exercise is suggested as one of the most
important healthy lifestyle strategies for optimal cardiovas-
cular aging.2,3,5,9
Interestingly, the effects of professional training (en-
durance or sprint) performed at a young age on cardiovascular
risk factors in former athletes is unclear. In general, the
analysis of mortality ratio and cause of death in the group of
elite athletes when compared with the general population
show that elite athletes live longer and possess lower
cardiovascular and cancer risks than the general popula-
tion.57–59 Moreover, with regard to athletes’ life span
longevities, some studies show a favorable survival outcome
for endurance-trained athletes (eg, long distance runners)
when compared with power sport (eg, weightlifters).57 The
recent analysis of the longevity and cause of death (overall
deaths) in the group of 2418 (455 died) of French elite
athletes, participants of the Olympic Games (from 1912 to
2012), revealed that indeed elite athletes lived  6.5 years
longer than the general population, but it was mainly driven by
lower risk of cancer.59 Interestingly, CVD-related mortality in
endurance and precision sports (targeting events) was not
significantly different from the general population, whereas
athletes from other sports disciplines (including power sports)
saved, on average, 1.6 years of life.
In the present study, we found no effect of professional
training performed at a young age (which was stopped
27 years earlier; see Table 1) on cardiovascular risk factors,
that is, central and peripheral arterial stiffness, central blood
pressure, cIMT (Figure 1), and brachial FMD (Figure 2A), in
former athletes. Moreover, in the former athletes, no effect of
the training performed in the past on inflammatory markers
(Figure 4A through 4F), LDL-cholesterol (Figure 3D), glucose
concentration (Figure 3E), and glycocalyx layer integrity
marker, prostacyclin, and NO• metabolites (Figure 2B through
2E) was observed. It is, however, worth noting that professional
training performed at a young age was linked with a more
preferable inflammatory profile, as judged by lower AAG in
young endurance-trained athletes (Figure 4C). However, after
training cessation, this effect disappeared and was not present
at an older age. Moreover, a clear tendency toward higher HDL-
cholesterol and lower insulin resistance assessed by HOMA-IR
in young and former endurance-trained athletes when com-
paredwith age-matched controls was found (Figure 3C and 3F),
which might suggest that endurance training performed at a
young age is indeed more preferable for cardiovascular health
and insulin sensitivity.60,61 However, as found in the present
study, at the age of 60, it has no impact on the age-related
increase in arterial stiffness and the attenuation of endothelial
function with aging (Figures 1 and 2).
The lack of a significant impact of training performed at a
young age on arterial stiffness and endothelial function might
be explained by the long gap from the end of professional
training (Table 1). Hence, our results show that the effects of
several years of professional training performed at a young
age were not generally maintained in older age.
As discussed above, one of the important determinants of
arterial stiffness is body fat as the major contributor of
chronic low-grade inflammation.21 In the present study, an
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age-dependent increase in body fat (Table 1) and inflamma-
tory markers—including TNF-a (Figure 4D)—was not modi-
fied by professional training performed at a young age. This
might explain the lack of an impact of professional training
performed in the past (27 years earlier) on the age-
dependent decline in endothelial function (Figure 2A) and
increased arterial stiffness (Figure 1A through 1C).
In this study, we also aimed to compare the effect of sprint
versus endurance training on the markers of cardiovascular
risk in young athletes. Surprisingly, we found no specific
effect of sprint versus endurance training on the cardiovas-
cular system at a young age and no delayed effects of sprint
versus endurance training on the cardiovascular system
(Figures 1 and 2). This provides evidence that the sprint
training conducted through sports carriers of professional
athletes (for several years; see Table 1) seems to have no
harmful effects on the cardiovascular system during carriers
as well as in older age, when compared with its status in
endurance athletes and in untrained controls.
Conclusions
In the present study, we found that professional training
(endurance or sprint) performed at a young age and regular
participation in sports events at a national/international level
did not influence the age-dependent decline in endothelial
function and an increase in arterial stiffness in older age.
Therefore, our results indicate that sports training at a young
age, then followed by the low-to-average physical activity level,
is not sufficient to slow down the age-related decline in
endothelial function and increase in arterial stiffness in men.
This result points to age as the major determinant of the status
of the arteries, which are not significantly influenced by the
history of several years of sports training performed at a young
age.
Study Limitations
One of the limitations of this study is a relatively small amount
of subjects within the study groups of athletes (n=15–16
individuals per group). Therefore, our study needs to be
expanded in the future to a larger cohort of athletes with
varying ages. It would also be interesting to see the
comparison of the studied indices of endothelial function
and blood variables in the former athletes and controls at a
more advanced age (eg, >80 years).
Another limitation to the study is that a couple of older
subjects (mainly from the control group, only 1 from former
endurance trained and 1 from former sprinters) were on
antihypertensive therapy. Further studies on the larger group of
subjects are mandatory to elucidate whether antihypertensive
therapy in a similar group as in the current study would affect
vascular aging. Nevertheless, it is unlikely that possible
favorable effects of antihypertensive drugs on vascular wall
aging in a control group would change the conclusion of our
study.
It should be underlined that our present study involved
male subjects only in order to avoid a potential impact of sex
differences on the time course of aging-related changes in
endothelial function and in arterial stiffness, as reported by
others.62,63 It should be stated that the conclusion of our
study cannot be simple extrapolated on the aging female
athletes in whom the time course of aging-related changes in
endothelial function and in arterial stiffness might be different
than in men.62,63 This is why further studies are needed to
establish the impact of aging in former high-class female
athletes and women with no history of physical training on the
endothelial function and arterial stiffness.
Moreover, further studies are needed to evaluate the
relationship between the changes in the VO2peak as an index
of cardiorespiratory fitness and the changes in vascular
function variables and cardiovascular disease risk parameters
in the time course of aging.
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